Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115833053 | 11583305 | 3 | F | 20141016 | 20160913 | 20151001 | 20160916 | EXP | US-009507513-1509USA014180 | MERCK | 17.00 | YR | M | Y | 62.00000 | KG | 20160916 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115833053 | 11583305 | 1 | PS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | COURSE A, B: 5 MG/M2, CYCLICAL TWICE DAILY ON DAYS 1-5. | 12675 | 5 | MG/M**2 | TABLET | |||||||
| 115833053 | 11583305 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | PROPHASE: 5MG/M2 (ONCE DAILY ON DAYS 1-2, AND TWICE DAILY ON DAYS 3-5) | 12675 | 5 | MG/M**2 | TABLET | QD | |||||||
| 115833053 | 11583305 | 3 | SS | DOXORUBICIN HYDROCHLORIDE. | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | COURSE B, 25 MG/M2, OVER 1-15 MIN. ON DAYS 1-5 | 0 | 25 | MG/M**2 | INJECTION | |||||||
| 115833053 | 11583305 | 4 | SS | CRIZOTINIB | CRIZOTINIB | 1 | Oral | COURSE A, B: 165 MG/M2, CYCLICAL (TWICE DAILY ON DAYS 1-21) | 0 | 165 | MG/M**2 | ||||||||
| 115833053 | 11583305 | 5 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Intrathecal | PROPHASE: 7.5-12 MG ON DAY 1 (AGE BASE DOSING) | 0 | ||||||||||
| 115833053 | 11583305 | 6 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Intravenous (not otherwise specified) | COURSE A,B: 3000 MG/M2, CYCLICAL OVER 3 HOURS ON DAY 1 | 0 | ||||||||||
| 115833053 | 11583305 | 7 | SS | CYTARABINE. | CYTARABINE | 1 | Intravenous (not otherwise specified) | COURSE A: 150 MG/M2, CYCLICAL OVER 1-30 MINUTES EVERY 12 HOURS ON DAYS 4 AND 5 | 0 | 150 | MG/M**2 | SOLUTION FOR INJECTION | |||||||
| 115833053 | 11583305 | 8 | SS | CYTARABINE. | CYTARABINE | 1 | Intrathecal | PROPHASE: 15-24 MG ON DAY 1 (AGE BASED DOSING) | 0 | SOLUTION FOR INJECTION | |||||||||
| 115833053 | 11583305 | 9 | SS | VP-16 | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | COURSE A: 100 MG/M2, CYCLICAL OVER 2 HOURS ON DAYS 4 AND 5 | 0 | 100 | MG/M**2 | ||||||||
| 115833053 | 11583305 | 10 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | Intravenous (not otherwise specified) | COURSE A: 800 MG/M2, CYCLICAL OVER 60 MIN ON DAYS 1-5 | 0 | 800 | MG/M**2 | ||||||||
| 115833053 | 11583305 | 11 | SS | NEULASTA | PEGFILGRASTIM | 1 | UNK | U | 0 | ||||||||||
| 115833053 | 11583305 | 12 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | PROPHASE: 200 MG/M2 OVER 15-30 MINUTES ON DAYS 1-2 | 0 | 200 | MG/M**2 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115833053 | 11583305 | 1 | Anaplastic large cell lymphoma T- and null-cell types |
| 115833053 | 11583305 | 3 | Anaplastic large cell lymphoma T- and null-cell types |
| 115833053 | 11583305 | 4 | Anaplastic large cell lymphoma T- and null-cell types |
| 115833053 | 11583305 | 5 | Anaplastic large cell lymphoma T- and null-cell types |
| 115833053 | 11583305 | 7 | Anaplastic large cell lymphoma T- and null-cell types |
| 115833053 | 11583305 | 9 | Anaplastic large cell lymphoma T- and null-cell types |
| 115833053 | 11583305 | 10 | Anaplastic large cell lymphoma T- and null-cell types |
| 115833053 | 11583305 | 12 | Anaplastic large cell lymphoma T- and null-cell types |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 115833053 | 11583305 | HO |
| 115833053 | 11583305 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115833053 | 11583305 | Back pain | |
| 115833053 | 11583305 | Hypertension |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115833053 | 11583305 | 1 | 20140708 | 0 | ||
| 115833053 | 11583305 | 5 | 20140708 | 0 | ||
| 115833053 | 11583305 | 7 | 20140708 | 0 | ||
| 115833053 | 11583305 | 12 | 20140708 | 0 |